Zhejiang Cheng Yi Pharmaceutical Co., Ltd. announced earnings guidance for the first half of 2019. The Company predicts that the net profit belonging to shareholders of the listed company in the 1st half of 2019 will be between RMB 67.3 million and RMB 69.3 million, with an increase of between RMB 22.29 million and RMB 24.29 million and an increase of between 49.5% and 54.0% compared with the same period of the year before. The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will be between RMB 58.4 million and RMB60.4 million with an increase of between RMB 13.32 million and RMB 15.32 million and an increase of between 29.6% and 34.0% compared with the same period of the year before.